Cellebrite DI Ltd. (CLBT) Quick Ratio
- Quick ratio · latest quarter: Value 1.03×; Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2025-12-31..
Quick ratio
Overview →Financial period ending 2025-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | 1.03× | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2025-12-31. $380.97M ÷ $369.66M ≈ 1.03× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | 380.97M USD | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 369.66M USD | Liabilities, Current |
| Cash and equivalents | 124.46M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 151.54M USD | Marketable Securities, Current |
| Customer receivables | 104.97M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 7.60M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $380.97M | $369.66M | $124.46M | $151.54M | $104.97M | $7.60M | 1.03× |
| 2025-06-30 | $419.26M | $309.97M | $179.22M | $146.91M | $93.13M | $9.54M | 1.35× |
| 2024-12-31 | $375.83M | $295.50M | $191.66M | $101.82M | $82.36M | $8.94M | 1.27× |
| 2024-06-30 | $178.71M | $237.23M | $106.96M | $71.63M | $125.00K | $8.78M | 0.75× |
| 2023-12-31 | $305.48M | $253.82M | $189.52M | $38.69M | $77.27M | $9.94M | 1.20× |
| 2023-06-30 | $168.22M | $204.51M | $110.50M | $57.60M | $112.00K | $10.82M | 0.82× |
| 2022-12-31 | (m) | $207.78M | (m) | $44.64M | $78.76M | $10.18M | (m) |
| 2022-06-30 | (m) | $172.87M | $91.69M | $32.44M | (m) | $8.12M | (m) |
| 2021-12-31 | (m) | $186.57M | (m) | (m) | $67.50M | $6.51M | (m) |
| 2020-12-31 | (m) | $159.38M | (m) | (m) | $66.32M | $4.75M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.